Ron H J Mathijssen - JoVE Visualize

Showing results (71-80 of 335) with videos related to

Pageof 34

Sort By:

Drugs|May 24, 2025

A Clinical Pharmacological Perspective on Intraperitoneal ChemotherapyPascale C S Rietveld, Niels A D Guchelaar, Sebastiaan D T Sassen, et al.

Journal of Pharmaceutical and Biomedical Analysis|August 30, 2011

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometryLisette Binkhorst, Ron H J Mathijssen, Inge M Ghobadi Moghaddam-Helmantel, et al.

Clinical and Translational Science|December 30, 2025

OATP2B1 Deficiency Ameliorates Irinotecan-Induced Gastrointestinal ToxicityHanieh Taheri, Peter de Bruijn, Yang Li, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010

Drug transporters and imatinib treatment: implications for clinical practiceKarel Eechoute, Alex Sparreboom, Herman Burger, et al.

Biochimica Et Biophysica Acta. Reviews on Cancer|November 2, 2020

Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitorsMarzia Del Re, Ron H N van Schaik, Stefano Fogli, et al.

Therapeutic Advances in Medical Oncology|January 16, 2019

Clinically relevant drug interactions with multikinase inhibitors: a reviewKoen G A M Hussaarts, G D Marijn Veerman, Frank G A Jansman, et al.

Journal of Pharmaceutical and Biomedical Analysis|May 4, 2019

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical applicationC Louwrens Braal, G D Marijn Veerman, Robert Peric, et al.

European Journal of Cancer (Oxford, England : 1990)|February 1, 2014

The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastasesGaia Schiavon, Alessandro Ruggiero, Dave J Bekers, et al.

Pharmacogenomics|January 19, 2013

CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycinLaure Elens, Annemieke Nieuweboer, Stephen J Clarke, et al.

Clinical Drug Investigation|January 12, 2022

Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM TrialC Louwrens Braal, Anne Kleijburg, Agnes Jager, et al.

Pageof 34

Showing results (71-80 of 335) with videos related to

Sort By:

Pageof 34

Drugs|May 24, 2025

A Clinical Pharmacological Perspective on Intraperitoneal ChemotherapyPascale C S Rietveld, Niels A D Guchelaar, Sebastiaan D T Sassen, et al.

Journal of Pharmaceutical and Biomedical Analysis|August 30, 2011

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometryLisette Binkhorst, Ron H J Mathijssen, Inge M Ghobadi Moghaddam-Helmantel, et al.

Clinical and Translational Science|December 30, 2025

OATP2B1 Deficiency Ameliorates Irinotecan-Induced Gastrointestinal ToxicityHanieh Taheri, Peter de Bruijn, Yang Li, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2010

Drug transporters and imatinib treatment: implications for clinical practiceKarel Eechoute, Alex Sparreboom, Herman Burger, et al.

Biochimica Et Biophysica Acta. Reviews on Cancer|November 2, 2020

Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitorsMarzia Del Re, Ron H N van Schaik, Stefano Fogli, et al.

Therapeutic Advances in Medical Oncology|January 16, 2019

Clinically relevant drug interactions with multikinase inhibitors: a reviewKoen G A M Hussaarts, G D Marijn Veerman, Frank G A Jansman, et al.

Journal of Pharmaceutical and Biomedical Analysis|May 4, 2019

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical applicationC Louwrens Braal, G D Marijn Veerman, Robert Peric, et al.

European Journal of Cancer (Oxford, England : 1990)|February 1, 2014

The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastasesGaia Schiavon, Alessandro Ruggiero, Dave J Bekers, et al.

Pharmacogenomics|January 19, 2013

CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycinLaure Elens, Annemieke Nieuweboer, Stephen J Clarke, et al.

Clinical Drug Investigation|January 12, 2022

Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM TrialC Louwrens Braal, Anne Kleijburg, Agnes Jager, et al.

Pageof 34